Clinical trials: Hypothyroxinemia
Glioblastoma Multiforme (GBM)
Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
The objective of the study is to assess the safety and efficacy of treatment with hypothyroxinemia adjunct to conventional therapies in GBM patients.
- Trial name
- NCT02654041
- Testing
- Combined T3 and Methimazole treatment
- Where
- Israel
- Volunteers
- 3 people
- Sponsor
- Musli Thyropeutics Ltd.